Dr. Richard Wright and Dr. C. Michael Gibson discuss: Transthyretin tetramer destabilization and increased mortality, and the physiologic importance of TTR.
Disclosures: Sponsored by BridgeBio Pharma, Inc
.
Search
Dr. Joshua Mitchell and Dr. C. Michael Gibson discuss: Transthyretin tetramer destabilization and increased mortality, and the physiologic importance of TTR.
Disclosures: Sponsored by BridgeBio Pharma, Inc.
Dr. M. Trejeeve Martyn and Dr. C. Michael Gibson discuss: The importance of early screening, diagnosis, and treatment for ATTR-CM
Disclosures: Sponsored by BridgeBio Pharma, Inc.
Dr. Adam Castano and Dr. C. Michael Gibson discuss: ACT-EARLY, a Phase 3 Study – Clinical Trial Results
Disclosures: Sponsored by BridgeBio Pharma, Inc
#ACC2025 Obesity Wrap Up:
Dr. Danielle Belardo and Dr. C. Michael Gibson discuss the PRAGUE-25 trial (catheter ablation vs. antiarrhythmics with weight management and […]